Using Targeted Radiotherapies to Fight Acute Myeloid Leukemia by Supporting Successful Transplants with Sandesh Seth Actinium Pharmaceuticals TRANSCRIPT
Download PDFSep 22, 2023
Sandesh Seth, the CEO and Chairman of Actinium Pharmaceuticals uses targeted radiotherapy to effectively destroy diseased bone marrow and allow new bone marrow to take over the immune functions. This approach offers a way for those currently unable to receive a transplant to have a chance for a transplant and...
Sep 22, 2023
Sandesh Seth, the CEO and Chairman of Actinium Pharmaceuticals uses targeted radiotherapy to effectively destroy diseased bone marrow and allow new bone marrow to take over the immune functions. This approach offers a way for those currently unable to receive a transplant to have a chance for a transplant and...
Expanding the Role of Pharmacists to Drive Drug Adherence and Whole-Person Care with Dr. Tony Willoughby Stellus Rx TRANSCRIPT
Download PDFAug 29, 2023
Dr. Tony Willoughby is the CEO of Stellus Rx, which has created a model of collaboration for the physician, patient, and pharmacist to provide a more robust system to encourage medication adherence and lifestyle changes. While clinicians may prescribe a treatment plan, pharmacists are in a position to work with...
Aug 29, 2023
Dr. Tony Willoughby is the CEO of Stellus Rx, which has created a model of collaboration for the physician, patient, and pharmacist to provide a more robust system to encourage medication adherence and lifestyle changes. While clinicians may prescribe a treatment plan, pharmacists are in a position to work with...
Developing Synthetic Anti-Infectives New Class of Antibiotics to Overcome Antimicrobial Resistance with James Graham Recce Pharmaceuticals TRANSCRIPT
Download PDFJul 31, 2023
James Graham is the CEO of Recce Pharmaceuticals, a biotechnology company focused on the global antibiotic-resistant patient population. This new class of synthetic antibiotics takes a broad-spectrum approach to kill bacterial infections, which continue to mutate, rendering existing antibiotics ineffective. The...